As of September 2024, Harbin Pharmaceutical Group has a market cap of $1.07B. This makes Harbin Pharmaceutical Group the world's 7480th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $991.97M | -16.42% |
2023 | $1.19B | 11.30% |
2022 | $1.07B | -15.21% |
2021 | $1.26B | 11.29% |
2020 | $1.13B | -15.83% |
2019 | $1.34B | -4.05% |
2018 | $1.40B | -32.01% |
2017 | $2.06B | -32.28% |
2016 | $3.04B | -6.50% |
2015 | $3.25B | 37.44% |
2014 | $2.37B | 41.60% |
2013 | $1.67B | -0.81% |
2012 | $1.68B | - |